EUROPE: New medical research priorities for 2010
August 1st, 2009
By Emma Jackson
Health graduate students and researchers at universities and research institutes across the EU have a chance to win funding for potentially lucrative research projects in the field of adverse drug reactions, after the European Medicines Agency (Emea) announced its 2010 drug safety research priorities. The money will come from the European Commission's Seventh Framework Programme (FP7).
Emea is an EU agency that promotes healthy populations by supervising and evaluating the use of medicines in humans and animals across Europe.
Choosing to focus ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.